Kevin Herbert Sells 2,000 Shares of Nature’s Sunshine Products (NASDAQ:NATR) Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Kevin Herbert sold 2,000 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $20.68, for a total value of $41,360.00. Following the completion of the sale, the executive vice president owned 48,866 shares of the company’s stock, valued at $1,010,548.88. This represents a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Nature’s Sunshine Products Stock Performance

NATR traded down $0.47 during midday trading on Monday, reaching $20.04. 136,943 shares of the company were exchanged, compared to its average volume of 120,488. Nature’s Sunshine Products, Inc. has a one year low of $12.97 and a one year high of $28.14. The stock has a market capitalization of $352.30 million, a P/E ratio of 18.22 and a beta of 0.86. The stock’s 50-day simple moving average is $23.76 and its 200 day simple moving average is $23.81.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.10. The company had revenue of $122.89 million during the quarter, compared to analysts’ expectations of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.

Analyst Ratings Changes

Several research firms have weighed in on NATR. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. DA Davidson restated a “buy” rating and issued a $33.00 price objective on shares of Nature’s Sunshine Products in a research report on Monday, May 11th. Finally, Canaccord Genuity Group set a $37.00 price objective on Nature’s Sunshine Products in a research note on Friday, May 8th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $35.00.

Institutional Trading of Nature’s Sunshine Products

Large investors have recently bought and sold shares of the business. State of Alaska Department of Revenue bought a new position in Nature’s Sunshine Products in the fourth quarter valued at approximately $31,000. New York State Teachers Retirement System bought a new stake in shares of Nature’s Sunshine Products during the first quarter worth $37,000. Raymond James Financial Inc. acquired a new stake in shares of Nature’s Sunshine Products during the second quarter worth $37,000. Clearstead Advisors LLC boosted its stake in Nature’s Sunshine Products by 16,025.0% in the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock worth $42,000 after purchasing an additional 1,923 shares during the period. Finally, McIlrath & Eck LLC acquired a new position in Nature’s Sunshine Products in the 1st quarter worth $48,000. 79.40% of the stock is owned by institutional investors.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.